|
|
|
|
| LEADER |
01000naa a22002652 4500 |
| 001 |
NLM121317293 |
| 003 |
DE-627 |
| 005 |
20231222192832.0 |
| 007 |
tu |
| 008 |
231222s1999 xx ||||| 00| ||eng c |
| 028 |
5 |
2 |
|a pubmed24n0405.xml
|
| 035 |
|
|
|a (DE-627)NLM121317293
|
| 035 |
|
|
|a (NLM)12322127
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 245 |
1 |
0 |
|a Australia ready for human vaccine trials
|
| 264 |
|
1 |
|c 1999
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 500 |
|
|
|a Date Completed 01.09.1999
|
| 500 |
|
|
|a Date Revised 15.11.2007
|
| 500 |
|
|
|a published: Print
|
| 500 |
|
|
|a Citation Status MEDLINE
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
4 |
|a Acquired Immunodeficiency Syndrome--prevention and control
|
| 650 |
|
4 |
|a Australia
|
| 650 |
|
4 |
|a Clinical Research
|
| 650 |
|
4 |
|a Clinical Trials
|
| 650 |
|
4 |
|a Developed Countries
|
| 650 |
|
4 |
|a Diseases
|
| 650 |
|
4 |
|a Hiv Infections--prevention and control
|
| 650 |
|
4 |
|a Human Volunteers
|
| 650 |
|
4 |
|a Oceania
|
| 650 |
|
4 |
|a Progress Report
|
| 650 |
|
4 |
|a Research Methodology
|
| 650 |
|
4 |
|a Vaccines
|
| 650 |
|
4 |
|a Viral Diseases
|
| 650 |
|
7 |
|a Vaccines
|2 NLM
|
| 773 |
0 |
8 |
|i Enthalten in
|t AIDS weekly plus
|d 1995
|g (1999) vom: 12. Apr., Seite 9
|w (DE-627)NLM098246348
|7 nnns
|
| 773 |
1 |
8 |
|g year:1999
|g day:12
|g month:04
|g pages:9
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_40
|
| 912 |
|
|
|a GBV_ILN_350
|
| 912 |
|
|
|a GBV_ILN_721
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|j 1999
|b 12
|c 04
|h 9
|